1,3,4-Oxadiazole,2,5-bis(4-methylphenyl)-

Suppliers

Names

[ CAS No. ]:
2491-91-0

[ Name ]:
1,3,4-Oxadiazole,2,5-bis(4-methylphenyl)-

[Synonym ]:
2,5-dip-tolyl-1,3,4-oxadiazole
1,3,4-OXADIAZOLE,2,5-BIS(4-METHYLPHENYL)
2,5-Di(4-methylphenyl)-1,3,4-oxadiazole
2,5-bis-(p-methylphenyl)-1,3,4-oxadiazole

Chemical & Physical Properties

[ Density]:
1.128g/cm3

[ Boiling Point ]:
399ºC at 760mmHg

[ Molecular Formula ]:
C16H14N2O

[ Molecular Weight ]:
250.29500

[ Flash Point ]:
189.3ºC

[ Exact Mass ]:
250.11100

[ PSA ]:
38.92000

[ LogP ]:
4.02040

[ Vapour Pressure ]:
3.26E-06mmHg at 25°C

[ Index of Refraction ]:
1.577

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RO0673500
CHEMICAL NAME :
1,3,4-Oxadiazole, 2,5-bis(4-methylphenyl)-
CAS REGISTRY NUMBER :
2491-91-0
BEILSTEIN REFERENCE NO. :
0214609
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C16-H14-N2-O
MOLECULAR WEIGHT :
250.32
WISWESSER LINE NOTATION :
T5NN DOJ CR D1& ER D1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
300 mg/kg
SEX/DURATION :
female 4-8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- Volume(issue)/page/year: 83,614,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
12500 ug/kg
SEX/DURATION :
female 4-8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- Volume(issue)/page/year: 83,614,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravaginal
DOSE :
44900 ug/kg
SEX/DURATION :
female 5 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
REFERENCE :
IJMRAQ Indian Journal of Medical Research. (Indian Council of Medical Research, Ansari Nagar, New Delhi 110 029, India) V.1- 1913- Volume(issue)/page/year: 83,614,1986

Safety Information

[ HS Code ]:
2934999090

Synthetic Route

Precursor & DownStream

Precursor

  • 2-p-tolyl-1,3,4-oxadiazole
  • Sodium toluene-4-sulphinate
  • Benzoic acid,4-methyl-, 2-(4-methylbenzoyl)hydrazide
  • 4-Methylbenzoic acid
  • p-Tolualdehyde
  • Benzoic acid,4-methyl-, hydrazide
  • 5-(4-Methylphenyl)-1H-tetrazole
  • p-toluoyl chloride
  • 4,5-dichloro-2-(4-methylbenzoyl)pyridazin-3-one
  • bis(4-methylbenzylidene)hydrazine

DownStream

  • 3,5-bis(4-methylphenyl)-4-phenyl-1,2,4-triazole
  • N,N'-Dibenzoylhydrazine
  • 1,3-Dimethyl-5-(4-methylbenzoyl)uracil-(4-methylbenzoyl)hydrazon
  • benzoic acid

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • 1,3,4-Oxadiazole,2,5-bis(4-methoxyphenyl)-
  • 1,3,4-Oxadiazole,2,5-bis(4-bromophenyl)-
  • 1,3,4-Oxadiazole,2,5-bis(4-chloro-3-nitrophenyl)-
  • 1,3,4-Oxadiazole, 2,5-bis[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
  • 2,5-bis(4-iodophenyl)-1,3,4-oxadiazole
  • 2-[5-(4-METHYL-BENZYL)-FURAN-2-YL]-[1,3,4]OXADIAZOLE
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 6-Methoxy-3,5-dimethyl-4(3H)-pyrimidinone
  • 2,3,5,6-Tetrafluoro-4-(hydroxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1E)-prop-1-en-1-yl]cyclopropanecarboxylate
  • 6-Methanesulfonylpyrazolo[1,5-a]pyrimidine-3-carbonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde